One alternative clinical trial approach that has gained steam due to the COVID-19 pandemic is the decentralized study, which makes it possible for research to be done virtually. Our infographic below sums up seven advantages and three key weaknesses of decentralized trials:
Our whitepaper, “Decentralizing research: How reducing patient burden improves trial diversity,” explores these types of trials in more detail, focusing on whether the alternative clinical trial approaches necessitated by the COVID-19 pandemic might improve trial diversity and ensure that more potential research participants have fair access to clinical trials. Download the whitepaper to learn more.
